ArticlebioRxiv : the preprint server for biology2026
Genetic background shapes AI-predicted variant effects.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Predicting the consequences of genetic variants remains a major goal in biomedicine. Conventional approaches typically assess single-nucleotide variants in the context of a single reference genome, without accounting for genetic diversity that can modulate variant effects. Here we introduce the personalized variant effect predictor (pVEP) framework, which quantifies how genetic background across thousands of human genomes from globally diverse populations shapes computational predictions of clinical variant effects. Across deep learning models spanning protein structure, splicing, and noncoding regulation, pVEP reveals that many clinical variants exhibit heterogeneous predicted effects across haplotypes, with the same variant predicted to be pathogenic in some genetic backgrounds and benign in others. We find support for underlying molecular mechanisms, including shifts in predicted protein contacts and changes in splice-site recognition. Overall, personalized genomic context emerges as a systematically underappreciated variable in variant annotation and clinical interpretation, with particular implications for genetically diverse populations.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.